Navigation Links
IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Date:11/1/2007

future events including statements regarding the Company's plans to collect, analyze and submit additional Phase 3 data in an amended NDA for L-MTP-PE and to respond to other matters raised by ODAC and the FDA, the Company's confidence that the proposed NDA amendment will provide substantial evidence for the continued regulatory approval process, the review of the submissions for marketing approval of L-MTP-PE by the FDA and the EMEA, and the Company's goal of making L-MTP-PE available to patients as quickly as possible. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, the possibility that the Company may not be able to collect, analyze and submit additional data in an amendment to the NDA for L-MTP-PE by the first quarter of 2008, if at all, the possibility that such data will not support the benefit of L-MTP-PE in the treatment of non-metastatic osteosarcoma, will not allow a more robust analysis of L-MTP-PE, will not continue to support its overall survival benefit in osteosarcoma, and may not provide substantial evidence for the potential regulatory approval of L-MTP-PE, the timing of the FDA's and EMEA's review of the submissions for marketing approval of L-MTP-PE, the ability of the Company to respond to questions raised by the FDA and EMEA in a satisfactory manner, the time needed to respond to any issues raised by the FDA and EMEA with regard to regulatory submissions for L-MTP-PE, the possibility that regulatory authorities may not consider preclinical and early clinical development work conducted by Ciba-Geigy and efficacy data from the Phase 3 trial conducted by Children's Oncology Group as adequate for their assessment of L-MTP-PE, which may cause delays in review, may result in the regulatory authorities requiring the Company to conduct additional clinical trials, or may result in a determination by the regulatory authorities that the data does not support marke
'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Serco Inc., a ... the Company has been awarded a re-compete contract ... (NEMSCOM) and its Deployable Medical Systems.  Serco will ... personnel to provide world-class healthcare to meet warfighter ... across the globe. The five year contract has ...
(Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
(Date:7/28/2014)...  VigeneTech, Inc, in collaboration with BioLegend, Inc., ... Software, an OEM software solution for analysis of ... offers varieties of bead-based multi-analyte immunoassay products for ... VigeneTech,s data analysis software, FCS data files can ... LEGENDplex™ software is a robust ...
Breaking Medicine Technology:Serco Awarded $22.7 Million Contract to Support Deployable Medical Systems 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3VigeneTech Releases New Powerful Software for Flow Cytometry Data Analysis 2
... HOUSTON , Jan. 25 Richard ... in his home on January 19th after a ... began his tenure at eCardio as Vice President, Business Development. ... initiatives. He was also responsible for identifying, negotiating and integrating ...
... , , CHICAGO ... (AIM), a leading diagnostic imaging benefit management and ... million consumers and an operating subsidiary of WellPoint, Inc. ( ... company,s patient safety section of its Web site at ...
Cached Medicine Technology:Richard Woodyard, Vice President of Sales at eCardio, Loses Fight Against Cancer 2American Imaging Management Launches New Patient Safety Program Podcasts 2American Imaging Management Launches New Patient Safety Program Podcasts 3
(Date:7/28/2014)... 2014 Mirena IUD lawsuits ( http://www.drugbot.com/mirena-iud/lawsuit/ ... some users to suffer serious injuries after it spontaneously ... to mount in U.S. courts, Bernstein Liebhard LLP reports. ... month in New Jersey, at least 924 Mirena lawsuits ... underway in Bergen County Superior Court. Some 148 claims ...
(Date:7/28/2014)... 2014 Lourdes Health System has partnered ... reduced wait times for veterans needing medical care. , ... the state—and the only one in Camden, Burlington and ... Care program (PC3). PC3 gives veterans access to specialty ... provide services due to lack of available specialists, long ...
(Date:7/28/2014)... July 28, 2014 Sarasota-based FCCI Insurance ... Companies To Work For. Still headquartered in Sarasota where ... only Florida-domiciled company in the top ten of the ... list appears in the August issue of Florida Trend ... large employer categories. Ranked #7 for 2014, FCCI has ...
(Date:7/28/2014)... The report, “Blowing Agents Market by Type, by ... to 2019” defines and segments the global blowing ... global consumption volume and value. , Browse more ... spread through 226 Pages and in-depth TOC on ... agents are highly utilized materials as a part ...
(Date:7/28/2014)... July 28, 2014 St. Jude Children’s ... of the Secretary of Defense Employer Support Freedom Award from ... the Department of Defense. The award is the highest honor ... support of employees who serve in the National Guard and ... the military for their contributions to the St. Jude mission ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 4Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 2Health News:FCCI Insurance Group Makes Top 100 Best Companies List – and is the Only Florida-Headquartered Company in Top Ten 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 2Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 3
... , TUESDAY, May 15 (HealthDay News) -- Black ... develop precancerous colorectal polyps, a new study finds. Researchers ... 50 and older who had a first-time colonoscopy screening at ... between 2006 and 2010. None of the patients had signs ...
... May 15 (HealthDay News) -- Researchers are preparing to test ... disease. The best-scenario hope is that the drug will ... and to a better understanding of its destructive processes, U.S. ... some Americans as well as 300 members of an extended ...
... TUESDAY, May 15 (HealthDay News) -- The lives of more ... 2004 and 2008 by the U.S. President,s Emergency Plan for ... adults, risk of death from all causes by 16 percent ... of Medicine researchers found. The researchers said this is the ...
... (HealthDay News) -- "Team-based care" should be used to ... on Community Preventive Services recommended on Tuesday. The ... that showed improvements in patients, control of blood pressure ... professionals -- a primary care doctor supported by a ...
... undergo radical surgery for prostate cancer may expect better ... hospitals with residency programs, and better still if the ... study by Henry Ford Hospital. The study, which ... throughout the U.S., also found that those with fewer ...
... Older, sicker, high-risk patients who undergo one of the ... in larger, busier hospitals, according to new research by ... research showed the experience level of the surgeon doing ... The results, based on data gathered throughout the ...
Cached Medicine News:Health News:Blacks, Hispanics Have Higher Colon Polyp Risk Than Previously Thought 2Health News:Trial Set to See if Drug Can Prevent Alzheimer's 2Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2